4978
ReproCELL Incorporated
リプロセル
- Industry
- Chemicals
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
1,286,284
Mar 2022
2,234,568
Mar 2023
2,953,272
Mar 2024
2,426,817
Mar 2025
2,978,627
Operating profit(thousand JPY)
Mar 2021
-1,048,046
Mar 2022
-647,127
Mar 2023
-356,224
Mar 2024
-409,293
Mar 2025
-130,409
Operating profit margin(%)
Mar 2021
-81.48
Mar 2022
-28.96
Mar 2023
-12.06
Mar 2024
-16.87
Mar 2025
-4.38
Profit before tax(thousand JPY)
Mar 2021
-811,937
Mar 2022
-573,944
Mar 2023
-303,662
Mar 2024
-28,870
Mar 2025
45,053
Profit(thousand JPY)
Mar 2021
-812,572
Mar 2022
-575,094
Mar 2023
-305,313
Mar 2024
-31,415
Mar 2025
103,245
Total assets(thousand JPY)
Mar 2021
6,047,488
Mar 2022
8,095,322
Mar 2023
8,355,848
Mar 2024
9,052,627
Mar 2025
9,670,755
Cash and cash equivalents(thousand JPY)
Mar 2021
2,601,406
Mar 2022
2,636,976
Mar 2023
1,914,569
Mar 2024
2,939,057
Mar 2025
2,823,367
Cash flows from operating activities(thousand JPY)
Mar 2021
-648,883
Mar 2022
-246,244
Mar 2023
-140,534
Mar 2024
-11,451
Mar 2025
6,287
Cash flows from investing activities(thousand JPY)
Mar 2021
-1,416,764
Mar 2022
-2,144,054
Mar 2023
-1,087,496
Mar 2024
404,424
Mar 2025
-795,995
Cash flows from financing activities(thousand JPY)
Mar 2021
4,410
Mar 2022
2,384,754
Mar 2023
482,872
Mar 2024
544,050
Mar 2025
680,110
Return on equity(%)
Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
1.2
Equity ratio(%)
Mar 2021
89
Mar 2022
89.5
Mar 2023
90.7
Mar 2024
91.8
Mar 2025
92.9
Earnings per share(JPY per share)
Mar 2021
-11.38
Mar 2022
-7.57
Mar 2023
-3.62
Mar 2024
-0.37
Mar 2025
1.11
Net assets per share(JPY per share)
Mar 2021
75.17
Mar 2022
88.11
Mar 2023
89.01
Mar 2024
93.41
Mar 2025
94.89
Dividend per share(-)
Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Payout ratio(-)
Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.